Preclinical models reveal that stress-induced amygdala activity and impairment in fear extinction
reflect reductions in anandamide driven by corticotropin-releasing hormone receptor type 1 (CRHR1) potentiation of
the anandamide catabolic enzyme fatty acid amide hydrolase.